Xiangyu Medical Reports 6% YoY Revenue Growth in First Three Quarters, Brain-Computer Interface Initiatives Open New Growth Avenues

Source: China Securities News·CSN

China Securities News (Wang Lu) -- On the evening of October 30,Sunnyou MedicalSunnyou Medical Releases Q3 2025 Report: Revenue Hits 537 Million Yuan, Up 6.00% YoY; Net Profit at 43.98 Million Yuan

In the third quarter of 2025, the company achieved operating revenue of 178 million yuan, a year-on-year increase of 5.5%; net profit attributable to parent company was 8.59 million yuan, and non-recurring net profit attributable to parent company was 6.91 million yuan.

The company continues to deepen its R&D efforts, with increasing investment in R&D becoming the core of growth.Driving ForceIn the first three quarters, the company's R&D expenses reached 125 million yuan, increasing by 8.85% year-on-year. The company obtained 87 new patents, including 30 new invention patents, and has cumulatively received 1,936 patents of various kinds; it also added 29 new provincial scientific and technological achievements, with a cumulative total of 277. Additionally, it won the third prize of the Military Science and Technology Progress Award.

Sunnyou Medical stated that in the field of brain-computer interface, multiple products have been successively approved. More than 80 large hospitals are using the company’s brain-computer interface rehabilitation equipment. As new products equipped with brain-computer interface technology gradually obtain registration certificates and enter the market, they will become a new growth point for the company's performance. It is expected to significantly boost the company’s performance by 2026.